Gentiopicroside promotes the osteogenesis of bone mesenchymal stem cells by modulation of β‐catenin‐BMP2 signalling pathway

Journal of Cellular and Molecular Medicine

Jialiang Zhong¹  Lufeng Yao²  Qiang Wu³  Wenjun Li³  Huaji Jiang⁴  Yung‐Kang Shen⁵  Cory J Xian⁶  Liping Wang⁶  Jianghui Dong⁶ 

[1] Department of Clinical Laboratory, The Seventh Affiliated Hospital, Sun Yat‐sen University, Shenzhen, China;Department of Foot and Ankle Surgery, Ningbo No. 6 Hospital, Ningbo, China;Department of Orthopaedic, Yuebei People's Hospital Affiliated to Medical College of Shantou University, Shaoguan, China;Department of Orthopaedic, Yuebei People's Hospital Affiliated to Medical College of Shantou University, Shaoguan, China;Department of Immunology, School of Basic Medical Science, Southern Medical University, Guangzhou, China;School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan;UniSA Clinical& Health Sciences, University of South Australia, Adelaide, SA, Australia;

关键词: BMP pathway;    Gentiopicroside;    osteogenic factors;    osteogenic parameters;    osteoporosis;    Wnt/β‐catenin pathway;   

DOI  :  10.1111/jcmm.16410

来源: Wiley

【 授权许可】

CC BY